Stock ASTH ASTRANA HEALTH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Astrana Health, Inc.

Equities

ASTH

US03763A2078

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
36.72 USD +0.44% Intraday chart for Astrana Health, Inc. -1.34% -4.13%
Apr. 24 Astrana Health, Inc. Announces Redesignation of Albert Young from Chief Administrative Officer to A New Role as Senior Vice President of Health Affairs CI
Apr. 02 Astrana Health Completes Acquisition of Community Family Care Medical Group MT

Evolution of the average Target Price on Astrana Health, Inc.

Price target over the last 5 years

History of analyst recommendation changes

d286.Y7EcPVwYMFCSYxJ_tG4EfHec_gmhMAtUuptFEeC-cSs.IOFGSCVSQhq_ImMOgVpLFxrrm0LQensj8fE3UJPkBRsO_V8OKEtnO9o8Kg~28ae167fa44568e4e071a3b84550b182

Analyst Recommendations on Astrana Health, Inc.

Truist Securities Adjusts Price Target on Astrana Health to $44 From $41, Maintains Hold Rating MT
Jefferies Starts Coverage on Apollo Medical With Buy Rating MT
Stifel Starts Coverage on Apollo Medical with Buy Rating, $45 Price Target MT
Truist Initiates Apollo Medical With Hold Rating, Price Target is $41 MT
BTIG Initiates Apollo Medical at Buy Rating With $45 Price Target MT
BofA Securities Initiates Apollo Medical at Neutral With $44 Price Target MT
Lake Street Adjusts Price Target on Apollo Medical Holdings to $60 From $40, Maintains Buy Rating MT
Lake Street Initiates Apollo Medical With Buy Rating, Sets $40 Price Target MT
William Blair Initiates Coverage on Apollo Medical Holdings With Outperform Rating MT
Barclays Adjusts Price Target on Apollo Medical Holdings to $57 From $50, Reiterates Equalweight Rating MT
Colliers Securities Assumes Apollo Medical Holdings at Buy with $93 Price Target MT
APOLLO MEDICAL : Barclays Starts Apollo Medical Holdings at Equal-Weight With $92 Price Target MT
APOLLO MEDICAL : Colliers Adjusts Price Target on Apollo Medical Holdings to $75 From $36, Maintains Buy Rating MT
Apollo Medical Holdings, Inc. Announces Successful Completion of Debt Refinancing, Reducing Annual Interest Rate Spread by 50 Basis Points CI
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
36.72 USD
Average target price
54 USD
Spread / Average Target
+47.06%
High Price Target
70 USD
Spread / Highest target
+90.63%
Low Price Target
44 USD
Spread / Lowest Target
+19.83%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Astrana Health, Inc.

Truist Securities
Jefferies & Co.
Stifel Nicolaus
BTIG
BofA Securities
Lake Street
William Blair & Co.
Barclays
Colliers Securities

Ratings for Astrana Health, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ASTH Stock
  4. Consensus Astrana Health, Inc.